Background: Cardiovascular disease (CVD) is the leading cause of mortality and morbidity
in patients with chronic kidney disease (CKD) including kidney transplant recipients (KTR) …

BACKGROUND: Due to their molecular weight, it is possible that the adipokines
adiponectin, resistin and leptin accumulate when glomerular filtration rate (GFR) is …

Background and aims Obesity is a pro-inflammatory risk factor for progression of CKD and
cardiovascular disease. We hypothesized that implementation of caloric restriction and …

The clinical effects and tolerability of a novel herbal formulation comprising the extracts of
Sphaeranthus indicus and Garcinia mangostana were assessed in two similarly designed …

OBJECTIVE: We investigate the effect of 6 months aerobic training alone or in combination
with diet on adiponectin in circulation and in adipose abdominal tissue (AT) in obese …

Increasing incidence of chronic kidney disease (CKD) which leads to end-stage renal
disease (ESRD) is one of the major health issues in the modern world and requires novel …

The multifactorial glycoprotein, adiponectin has demonstrable insulin‐sensitizing, anti‐
atherogenic and anti‐inflammatory properties. However, despite the prevalence of both …

Zinc-α2-glycoprotein (ZAG), a potent cachectic factor, is increased in patients undergoing
maintenance dialysis. However, there is no data for patients before initiation of renal …

Background High sodium intake is associated with increased risk of end-organ damage,
independent of blood pressure (BP) levels. The protective peptide adiponectin may play a …

Enhanced chronic inflammation and reduced insulin sensitivity are often present in chronic
kidney disease (CKD). Cardiovascular disease remains a major cause of morbidity and …